Literature DB >> 20219982

Phospholipase D2 mediates acute aldosterone secretion in response to angiotensin II in adrenal glomerulosa cells.

Haixia Qin1, Michael A Frohman, Wendy B Bollag.   

Abstract

In primary bovine adrenal glomerulosa cells, the signaling enzyme phospholipase D (PLD) is suggested to mediate priming, the enhancement of aldosterone secretion after pretreatment with and removal of angiotensin II (AngII), via the formation of persistently elevated diacylglycerol (DAG). To further explore PLD's role in priming, glomerulosa cells were pretreated with an exogenous bacterial PLD. Using this approach, phosphatidic acid (PA) is generated on the outer, rather than the inner, leaflet of the plasma membrane. Although PA is not readily internalized, the PA is nonetheless rapidly hydrolyzed by cell-surface PA phosphatases to DAG, which efficiently flips to the inner leaflet and accesses the cell interior. Pretreatment with bacterial PLD resulted in priming upon subsequent AngII exposure, supporting a role of DAG in this process, because the increase in DAG persisted after exogenous PLD removal. To determine the PLD isoform mediating aldosterone secretion, and presumably priming, primary glomerulosa cells were infected with adenoviruses expressing GFP, PLD1, PLD2, or lipase-inactive mutants. Overexpressed PLD2 increased aldosterone secretion by approximately 3-fold over the GFP-infected control under basal conditions, with a significant enhancement to about 16-fold over the basal value upon AngII stimulation. PLD activity was also increased basally and upon stimulation with AngII. In contrast, PLD1 overexpression had little effect on aldosterone secretion, despite the fact that PLD activity was enhanced. In both cases, the lipase-inactive PLD mutants showed essentially no effect on PLD activity or aldosterone secretion. Our results suggest that PLD2 is the isoform that mediates aldosterone secretion and likely priming.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219982      PMCID: PMC2869249          DOI: 10.1210/en.2009-1159

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  34 in total

1.  The activation of phospholipase D by endothelin-1, angiotensin II, and platelet-derived growth factor in vascular smooth muscle A10 cells is mediated by small G proteins of the ADP-ribosylation factor family.

Authors:  K Shome; M A Rizzo; C Vasudevan; B Andresen; G Romero
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

2.  Short term memory in the calcium messenger system. Evidence for a sustained activation of protein kinase C in adrenal glomerulosa cells.

Authors:  P Q Barrett; I Kojima; K Kojima; K Zawalich; C M Isales; H Rasmussen
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

3.  Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR.

Authors:  B T Andresen; E K Jackson; G G Romero
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Phosphorylation, transbilayer movement, and facilitated intracellular transport of diacylglycerol are involved in the uptake of a fluorescent analog of phosphatidic acid by cultured fibroblasts.

Authors:  R E Pagano; K J Longmuir
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

6.  Angiotensin II priming of aldosterone secretion with agents that enhance Ca(2+) influx.

Authors:  S Betancourt-Calle; R S Mann-Blakeney; C M Isales; R A Calle; W Bollinger Bollag
Journal:  Mol Cell Endocrinol       Date:  2001-05-25       Impact factor: 4.102

7.  Purification of Streptomyces chromofuscus phospholipase D by hydrophobic affinity chromatography on palmitoyl cellulose.

Authors:  S Imamura; Y Horiuti
Journal:  J Biochem       Date:  1979-01       Impact factor: 3.387

8.  AngII induces transient phospholipase D activity in the H295R glomerulosa cell model.

Authors:  Xiangjian Zheng; Wendy B Bollag
Journal:  Mol Cell Endocrinol       Date:  2003-08-29       Impact factor: 4.102

9.  Mechanism of angiotensin II-induced phospholipase D activation in bovine adrenal glomerulosa cells.

Authors:  Wendy B Bollag; EunMi Jung; Roberto A Calle
Journal:  Mol Cell Endocrinol       Date:  2002-06-28       Impact factor: 4.102

10.  5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis.

Authors:  Wenjuan Su; Oladapo Yeku; Srinivas Olepu; Alyssa Genna; Jae-Sook Park; Hongmei Ren; Guangwei Du; Michael H Gelb; Andrew J Morris; Michael A Frohman
Journal:  Mol Pharmacol       Date:  2008-12-08       Impact factor: 4.436

View more
  10 in total

Review 1.  Acute and chronic regulation of aldosterone production.

Authors:  Namita G Hattangady; Lawrence O Olala; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-08-04       Impact factor: 4.102

Review 2.  The phospholipase D superfamily as therapeutic targets.

Authors:  Michael A Frohman
Journal:  Trends Pharmacol Sci       Date:  2015-02-03       Impact factor: 14.819

3.  Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL).

Authors:  Yewei Xing; William E Rainey; John W Apolzan; Omar L Francone; Ruth B S Harris; Wendy B Bollag
Journal:  Endocrinology       Date:  2011-12-20       Impact factor: 4.736

Review 4.  Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production.

Authors:  Ying-Ying Tsai; William E Rainey; Wendy B Bollag
Journal:  J Endocrinol       Date:  2016-12-02       Impact factor: 4.286

5.  VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production.

Authors:  Ying-Ying Tsai; William E Rainey; Maribeth H Johnson; Wendy B Bollag
Journal:  Mol Cell Endocrinol       Date:  2016-05-21       Impact factor: 4.102

6.  A role for phospholipase D in angiotensin II-induced protein kinase D activation in adrenal glomerulosa cell models.

Authors:  Lawrence O Olala; Mutsa Seremwe; Ying-Ying Tsai; Wendy B Bollag
Journal:  Mol Cell Endocrinol       Date:  2012-11-20       Impact factor: 4.102

7.  Phospholipase D2 loss results in increased blood pressure via inhibition of the endothelial nitric oxide synthase pathway.

Authors:  Rochelle K Nelson; Jiang Ya-Ping; John Gadbery; Danya Abedeen; Nicole Sampson; Richard Z Lin; Michael A Frohman
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

Review 8.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

9.  Phospholipase D1 regulation of TNF-alpha protects against responses to LPS.

Authors:  Marc-Andre Urbahn; Sonja Charlotte Kaup; Friedrich Reusswig; Irena Krüger; Martina Spelleken; Kerstin Jurk; Meike Klier; Philipp A Lang; Margitta Elvers
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

Review 10.  The role of lipid second messengers in aldosterone synthesis and secretion.

Authors:  Shinjini C Spaulding; Wendy B Bollag
Journal:  J Lipid Res       Date:  2022-03-10       Impact factor: 6.676

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.